Clinical factors predictive of Crohn's disease complications and surgery

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 2, 2013, Pages 129-134

  Cerqueira, Rute Maria ^a   Lago, Paula M ^b  

^a Hospital So Sebastio   (Portugal)

^b Centro Hospitalar e Universitário do Porto   (Portugal)

Author keywords

Abscess; Crohn's disease; Fistulae; Prognosis; Risk factors; Strictures; Surgery

Indexed keywords

CORTICOSTEROID; IMMUNOSUPPRESSIVE AGENT;

ABDOMINAL PAIN; ARTHRALGIA; COLON DISEASE; CORTICOSTEROID THERAPY; CROHN DISEASE; DIARRHEA; DISEASE SEVERITY; ENTERITIS; FATIGUE; FEVER; GASTROINTESTINAL SURGERY; HAZARD RATIO; HIGH RISK PATIENT; HOSPITALIZATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; MEDLINE; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; REVIEW; RISK FACTOR; SMOKING; SURGICAL TECHNIQUE; SYMPTOM; SYSTEMATIC REVIEW; UPPER GASTROINTESTINAL TRACT; UVEITIS;

CONSTRICTION, PATHOLOGIC; CROHN DISEASE; DISEASE PROGRESSION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INTESTINAL FISTULA; INTESTINAL OBSTRUCTION; PROGNOSIS; RISK FACTORS;

EID: 84872072729     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e32835a7eed     Document Type: Review

References (27)

1. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, et al. A simple classification of Crohn's disease: Report of the Working Party for the World Congress of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 2000; 6:8-15
2. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol 2005; 19 (SUPPLA):5-36
3. Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Long-Term evolution of disease behaviour of Crohn's disease. Inflamm Bowel Dis 2002;244-250 (Pubitemid 34784976)
4. Thia KT, Sandborn WJ, Harmsen WS, Zinsmeisrer AR, Loftus EV. Risk factors associated with progression to intestinal complications of Crohn's disease in a population based cohort study. Gastroenterology 2010; 139:1147-1155
5. Tarrant KM, Barclay ML, Frampton CMA, Gearry RB. Perianal disease predicts change in Crohn's disease phenotype - results of a population based study of Inflammatory bowel disease phenotype. Am J Gastroenterol 2008; 103:3082-3093
6. Louis E, Collard A, Oger AF, Degroote E, Abdoul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: Changing pattern over the course of disease. Gut 2001; 49:777-782 (Pubitemid 33096034)
7. Peyrin- Biroulet L, Loftus EV Jr, Colombel JF, Sandborn WJ. The natural history of adult Crohn's disease in populations-based cohorts. Am J Gastroenterol 2010; 105:289-297
8. Lichtentstein GR, Yan S, Bala M, Blank M, Sands BE. Infliximab maintenance treatment reduces hospitalizations, surgeries, and procedures in fistulising Crohn's disease. Gastroenterology 2005; 128:862-869 (Pubitemid 40523539)
9. Feagan BG, Panaccione R, Sandborn WJ, D'Haens GR, Schreiber S, Rutgeerts PJ, et al. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: Results from the Charm Study. Gastroenterology 2008; 135:1493-1499
10. Peyrin-Biroulet Oussalah A,Wiliet N, Pillot C, Bresler L, Bigard MA. Impact of azathriopine and tumor necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 2011; 60:930-936
11. Devlin SM, Panaccione R. Evolving inflammatory bowel disease treatment paradigms: Top-Down versus step-up. Med Clin North Am 2010; 94:1-18
12. Beaugerie L, Brousse N, Bouvier AM, Colombel JF, Le'mann M, Cosnes J, et al. Lymphoproliferative disorders in patients receiving thiopurines for inflammatory bowel disease: A prospective observational cohort study. Lancet 2009; 374:1617-1625
13. Sokol H, Beaugerie L. Inflammatory bowel disease and lymphoproliferative disorders: The dust is starting to settle. Gut 2009; 58:1427-1436
14. Armstrong RG, West G, Card TR. Risk of cancer in inflammatory bowel disease treated with azathioprine: A UK population based case- control study. Am J Gastroenterology 2010; 105:1604-1609
15. Viget N, Vernier-Massouille G, Salmon Ceron D, Yazdanpanah Y, Colombel JF. Opportunistic infection in patients with inflammatory bowel disease: Prevention and diagnosis. Gut 2008; 57:549-558 (Pubitemid 351442541)
16. Toruner M, Loftus EV Jr, Harmsen WS, Zinsmeister AR, Orenstein R, Sandborn WJ, et al. Risk factors for opportunistic infections in patients with inflammatory bowel disease. Gastroenterology 2008; 134:929-936 (Pubitemid 351451967)
17. Lichtenstein G, Feagan B, Cohen RD, Salzberg BA, Diamond RH, Chen DM, et al. Serious infection and mortality in association with therapies for Crohn's disease: TREAT Registry. Clin Gastroenterol Hepatol 2006; 4:621-630
18. Solberg IC, Vatn MH, Hoie O, Stray N, Sauar J, Jahnsen J, et al. Clinical Course in Crohn's disease: Results of a Norwegian population based ten year follow-up study. Clin Gastroenterol Hepatol 2007; 5:1430-1438 (Pubitemid 350181602)
19. Beaugerie L, Seksik P, Nion-Larmurier I, Gendre JP, Cosnes J. Predictors of Crohn's disease. Gastroenterology 2006; 130:650-656 (Pubitemid 43374514)
20. Romberg-Camps MJL, Dagnelie PC, Kester ADM, Hesselink-Van de Kruijs MAM, Cilissen M, Engels LGJB, et al. Influence of phenotype at diagnosis and other potential prognostic factors on the course of inflammatory bowel disease. Am J Gastroenterol 2009; 104:371-383
21. Louis E, Michel V, Hugot JP, Reenaers C, Fontaine F, Delforge M, et al. Early development of structuring or penetrating pattern in Crohn's disease is influenced by disease location, number of flares, and smoking but not by NOD2/CARD15 genotype. Gut 2003; 52:552-557 (Pubitemid 36363410)
22. Lakatos PL, Czegledi Z, Szamosi T, Banai J, David G, Zsigmond F, et al. Perianal disease, small bowel disease, smoking, prior steroid or early azathriopine/biological therapy are predictors of disease behaviour change in patients with Crohn's disease. World J Gastroenterol 2009; 15: 3504-3510
23. Aldhous MC, Drummond HE, Anderson N, Smith LA, Arnott I, Satsangi J. Does cigarette smoking influence the phenotype of Crohn's disease? Analysis using the Montreal classification. Am J Gastroenterol 2007; 102:577-588 (Pubitemid 46328158)
24. Loly C, Belaiche J, Louis E. Predictors of severe Crohn's disease. Scand J Gastroenterol 2008; 43:948-954
25. Song X, Gao X, Li M, Chen Z, Chen S, Hu P, et al. Clinical features and risk factors for primary surgery in 205 patients with Crohn's disease: Analysis of a South China cohort. Dis Colon Rectum 2011; 54: 1147-1154
26. Mahid SS, Minor KS, Stevens PL, Galandiuk S. The role of smoking in Crohn's disease as defined by clinical variables. Dig Dis Sci 2007; 52:2897-2903 (Pubitemid 47512518)
27. Seksik P, Nion-Larmurier I, Sokol H, Beaugerie L, Cosnes J. Effects of light smoking on the clinical course of Crohn's disease. Inflamm Bowel Dis 2009; 15:734-741